Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Decline Accept
Home › Fund moves › Revvity › EdgePoint Investment Group Inc. cut its RVTY stake below 5% (4.8%) Fund moves
Stake · was 7.4%
Shares owned
Why it stands out The holder reported owning less than 5%, which ends its duty to keep reporting this stake.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
All the details
Dates, kept separate
Date of the event that required the filing Sep 30, 2026
Reporting period Not applicable
Filed with the SEC Nov 16, 2026 passive 5% holder
Context Change vs prior quarter Undefined
Compared with the manager's prior 13F
Tracked managers with the same change NaN
For the same quarter
0001172661-26-005422
Data quality Verified: identifiers matched exactly
Around the same time Fund moves
From a 13F filed Nov 16, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Congress
Traded Oct 27 · disclosed 14 days later
Congress
Traded Sep 9 · disclosed 33 days later
The story around this disclosure Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
Aug 4, 2026 Company filing · Form 8-K · Results, Other news Reported its results, and reported other company news Aug 14, 2026 5% stake T. Rowe Price Associates, Inc. reported a passive stake (13G) of 5.0% Aug 14, 2026 5% stake T. Rowe Price Investment Management, Inc. reported a passive stake (13G) of 16.4% Sep 3, 2026 Congress Disclosed partial sale of RVTY — reported range $1,001 - $15,000 Sep 4, 2026 Congress Disclosed partial sale of RVTY — reported range $1,001 - $15,000 Sep 8, 2026 5% stake T. Rowe Price Investment Management, Inc. reported a passive stake (13G) of 9.2% Sep 9, 2026 Congress Disclosed partial sale of RVTY — reported range $15,001 - $50,000 Sep 16, 2026 Insider · Their largest sale since 2022 Officer sold ~$1.03M of RVTY shares in the open market Sep 21, 2026 Insider Officer sold ~$236K of RVTY shares in the open market Sep 30, 2026 FDA FDA device clearance: Eonis SMA kit Sep 30, 2026 Federal contract · $2.0M obligated Department of Health and Human Services awarded Revvity: $2.01M obligated to date What came next Oct 1, 2026 Insider Officer sold ~$13K of RVTY shares in the open market Oct 7, 2026 5% stake T. Rowe Price Associates, Inc. reported a passive stake (13G) of 11.8% Oct 27, 2026 Congress Disclosed partial sale of RVTY — reported range $1,001 - $15,000 Nov 3, 2026 Company filing · Form 8-K · Results, Other news Reported its results, and reported other company news